151 related articles for article (PubMed ID: 32325008)
1. GPR39 Overexpression in OSCC Promotes YAP-Sustained Malignant Progression.
Jiang Y; Li T; Wu Y; Xu H; Xie C; Dong Y; Zhong L; Wang Z; Zhao H; Zhou Y; Li J; Ji N; Zeng X; Feng X; Chen Q
J Dent Res; 2020 Jul; 99(8):949-958. PubMed ID: 32325008
[TBL] [Abstract][Full Text] [Related]
2. Yes-associated protein promotes cell migration via activating Wiskott-Aldrich syndrome protein family member 1 in oral squamous cell carcinoma.
Qi L; Shi C; Li J; Xu S; Han Y; Li J; Zhang L
J Oral Pathol Med; 2019 Apr; 48(4):290-298. PubMed ID: 30697796
[TBL] [Abstract][Full Text] [Related]
3. The role of YAP in the control of the metastatic potential of oral cancer.
Ahmad US; Saravanan K; Wan H
Oncol Res; 2021; 29(6):377-391. PubMed ID: 37304649
[TBL] [Abstract][Full Text] [Related]
4. Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells.
Ahmad US; Parkinson EK; Wan H
Mol Oncol; 2022 Apr; 16(8):1625-1649. PubMed ID: 35000271
[TBL] [Abstract][Full Text] [Related]
5. Expression of Yes-associated Protein in Oral Squamous Cell Carcinoma.
Shelke P; Sarode GS; Sarode SC; Maniyar N; Prajapati G; Patil S
J Contemp Dent Pract; 2019 Aug; 20(8):887-892. PubMed ID: 31797842
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis using ATN as a novel Yes-associated protein inhibitor in human oral squamous cell carcinoma cells.
Chu PC; Dokla EME; Hu JL; Weng JR
Environ Toxicol; 2022 Jun; 37(6):1404-1412. PubMed ID: 35212453
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
8. C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC.
Chen X; Gu W; Wang Q; Fu X; Wang Y; Xu X; Wen Y
Oncotarget; 2018 Jan; 9(1):668-679. PubMed ID: 29416644
[TBL] [Abstract][Full Text] [Related]
9. Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts.
Kim DK; Kim EK; Jung DW; Kim J
PLoS One; 2019; 14(3):e0214553. PubMed ID: 30921404
[TBL] [Abstract][Full Text] [Related]
10. LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma.
Dong C; Wei KJ; Zhang WB; Sun H; Pan HY; Zhang L
J Oral Pathol Med; 2015 Jul; 44(6):475-81. PubMed ID: 25782587
[TBL] [Abstract][Full Text] [Related]
11. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
[TBL] [Abstract][Full Text] [Related]
12. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
[TBL] [Abstract][Full Text] [Related]
13. GPCR-Hippo Signaling in Cancer.
Luo J; Yu FX
Cells; 2019 May; 8(5):. PubMed ID: 31072060
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.
Rot S; Kaune T; Taubert H; Greither T; Kotrba J; Güttler A; Wichmann H; Bilkenroth U; Wienke A; Al-Nawas B; Bache M; Vordermark D; Wickenhauser C; Bethmann D; Eckert AW; Kappler M
BMC Cancer; 2019 Feb; 19(1):155. PubMed ID: 30770730
[TBL] [Abstract][Full Text] [Related]
15. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway.
Liu Z; Li H; Fan S; Lin H; Lian W
Cancer Biol Ther; 2019; 20(4):444-453. PubMed ID: 30404566
[TBL] [Abstract][Full Text] [Related]
16. The ZnR/GPR39 interacts with the CaSR to enhance signaling in prostate and salivary epithelia.
Asraf H; Salomon S; Nevo A; Sekler I; Mayer D; Hershfinkel M
J Cell Physiol; 2014 Jul; 229(7):868-77. PubMed ID: 24264723
[TBL] [Abstract][Full Text] [Related]
17. Cell division cycle 7 is a potential therapeutic target in oral squamous cell carcinoma and is regulated by E2F1.
Jin S; Ma H; Yang W; Ju H; Wang L; Zhang Z
J Mol Med (Berl); 2018 Jun; 96(6):513-525. PubMed ID: 29713760
[TBL] [Abstract][Full Text] [Related]
18. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
[TBL] [Abstract][Full Text] [Related]
19. Orchestration of Intracellular Circuits by G Protein-Coupled Receptor 39 for Hepatitis B Virus Proliferation.
Goto K; Nishitsuji H; Sugiyama M; Nishida N; Mizokami M; Shimotohno K
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784555
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
